The Pharma Data

MAY 5, 2021

ELI LILLY & Co. Source link.

52

52

Pharmaceutical Technology

APRIL 19, 2023

GSK expects that the BELLUS Health acquisition will boost its speciality medicines and respiratory pipeline. This proposed acquisition complements our portfolio of speciality medicines and builds on our expertise in respiratory therapies.” GSK will buy all the outstanding shares in BELLUS for $14.75 per share in cash.

Medicine 243

Medicine Sales Clinical Development Trials 243

BioTech 365

OCTOBER 23, 2020

CALGARY, Alberta, Oct. 23, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the results of the … Continue reading →

Development 40

Development 40

Drug Channels

MARCH 7, 2024

On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. This report—our fifteenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S. This means that you can be among the first to access our new report. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 79

Pharmacy Licensing Licensing Drugs 79

Medical Xpress

MAY 12, 2023

Two specialized researchers, one with the Leibniz-Institut für Wissensmedien (the Knowledge Media Research Center), the other with the Applied Face Cognition Lab at the University of Lausanne, have validated reports that some people have super-recognizing abilities.

Research 116

Research 116

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

Pharmacy 113

Pharmacy Containment Manufacturing Business Development 113

Fierce Pharma

OCTOBER 2, 2023

ICER submitted a special report to CMS weighing evidence on Bristol Myers Squibb and Pfizer’s Eliquis and Bayer and Johnson & Johnson’s Xarelto to treat nonvalvular atrial fibrillation (NVAF), the condition where both drugs garner most of their prescriptions. As a new age of price negotiations dawns in the U.S.,

Drugs 109

Drugs 109

Medical Xpress

FEBRUARY 16, 2023

The Strategically Focused Research Network (SFRN) on Obesity has published its findings in a Journal of the American Heart Association special report, which hails the group's work as "the beginning of innovative science, and importantly, the birth of new collaborations and research partnerships to propel the field forward."

Research 98

Research Cardiology 98

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. The table below—one of 262 in our new report—provides DCI's first look at the 15 largest organizations that battled for those revenues. We’re offering special discounted pricing if you order before April 7, 2024.

Pharmacy 81

Pharmacy Marketing Drugs 81

Medical Xpress

MAY 4, 2023

Scientists from Singapore have demonstrated the critical role played by a special transporter protein in regulating the brain cells that ensure nerves are protected by coverings called myelin sheaths.

Research 98

Research Protein Regulation Scientist 98

Drug Channels

MARCH 19, 2024

I am pleased to announce our new 2024 Economic Report on U.S. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. The 2024 Economic Report on U.S. Read on for some additional details.

Pharmacy 72

Pharmacy Licensing Licensing Drugs 72

Medical Xpress

NOVEMBER 13, 2022

A new study from researchers at Hospital for Special Surgery (HSS) has evaluated trends in the use of total knee arthroplasty (TKA) in patients under 21 in the United States. The study was reported at the American College of Rheumatology (ACR) Convergence 2022 meeting (abstract number 08780).

Research 98

Research 98

BioPharma Reporter

MARCH 25, 2022

Exothera, a CDMO specializing in the industrialization of vaccine and gene therapy processes, reports that it has achieved GMP certification for its facilities in Jumet, Belgium.

Gene Therapy 93

Gene Therapy Gene Vaccination Vaccine 93

BioPharma Reporter

OCTOBER 30, 2023

Peter Walters is a fellow of Advanced Therapies at CRB and has 20 years of experience specializing in pharmaceutical process and facility design. We spoke to him about CRB's latest life sciences report and best practices that must be adopted across the industry.

Life Science 52

Life Science Development 52

Scienmag

NOVEMBER 29, 2021

[link] Credit: FSR [link] Special Issue: Sharing Clinical and Forensic Toxicology Knowledge in the Era of a Pandemic and Beyond This special issue includes an editorial, one review, five research articles and two case reports from leading scientists in the field that further the discussion on clinical and forensic toxicology.

Research 82

Research Scientist Medicine 82

Medical Xpress

NOVEMBER 21, 2022

A researcher at the University of Houston College of Pharmacy is reporting an effective protocol for reprogramming human heart cells into specialized cells that conduct electricity throughout the heart to enable rhythmic heartbeat and repair diseased hearts.

Pharmacy 75

Pharmacy Research 75

Rethinking Clinical Trials

AUGUST 17, 2023

To address these questions, the American Journal of Bioethics ( AJOB ) recently published commentaries on 2 target articles in a special issue on pragmatic clinical trials. Both of the target articles for the special issue are from the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

FDA Law Blog

OCTOBER 30, 2023

Houck — The Drug Enforcement Administration (“DEA”) has issued its notice finalizing updates to its longstanding Special Surveillance List of chemicals and equipment used in the illicit manufacture of controlled substances and listed chemicals. DEA’s notice of updates with the Special Surveillance List is attached here. 73,044 (Oct.

Manufacturing 59

Manufacturing Containment Production Regulation 59

Medical Xpress

MARCH 10, 2023

The rapid transition from in-person to care to telemedicine visits at the start of the COVID‑19 pandemic did not adversely affect the quality of care—and even improved some aspects of care—for patients with major depression in a major integrated health system, according to a new report.

77

77

Scienmag

DECEMBER 16, 2021

The percentage of infants fully breastfed at 1,3, and 6 months significantly decreased during the COVID-19 pandemic among participants of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in Southern California.

Medicine 91

Medicine 91

Worldwide Clinical Trials

DECEMBER 7, 2023

As a result, various CROs have undergone significant consolidations and acquisitions of specialized capabilities to address the escalating complexity in clinical trials. At Worldwide, we understand that every program is different, which means every drug development path forward will be unique.

Clinical Development 331

Clinical Development Clinical Trials Clinical Trials Trials 331

STAT News

OCTOBER 31, 2022

The promise of personalized medicine — safer and more effective treatments tailored to each individual’s body and needs — isn’t being fully met because of challenges associated with its implementation in clinical practice.

Medicine 98

Medicine Genetics Drugs 98

Pharmaceutical Technology

DECEMBER 7, 2022

A reduced number of serious and severe adverse reactions (AR) were reported and balanced between the vaccine and placebo arms. . Additionally, Nuvaxovid was found to be well-tolerated in the paediatric expansion, the preliminary safety data showed.

Vaccination 264

Vaccination Vaccine Protein Clinical Trials 264

Pharmaceutical Technology

APRIL 20, 2023

Japanese MHLW’s new NHI drug price revisions for FY2023 account for 36% of products receiving price increases in April 2023 As part of the new revision, two special measures were introduced to ensure a stable drug supply by either maintaining or increasing the listed prices of designated drugs.

Drugs 130

Drugs Branding Production Manufacturing 130

Medical Xpress

APRIL 25, 2023

Understanding the structural characteristics that underlie behavioral deficits can aid in designing special education programs for children with autism. A paper with the study's findings has been published in Scientific Reports. These regions play a critical role in language functioning.

Research 75

Research 75

STAT News

NOVEMBER 15, 2022

We explore some of the key looming questions here, going beyond a recent STAT News special report that chronicles this academic exodus and looking ahead to the future. The unprecedented departure of young life science Ph.D.s

Life Science 98

Life Science Scientist Research 98

Medical Xpress

DECEMBER 15, 2022

Just as a fire department mobilizes in response to a reported fire, specialized immune cells in the body mobilize in response to the introduction of foreign substances known as antigens. Plasma cells are an important type of immune cell that release antibodies (or protective proteins) that act to neutralize antigens.

Protein 74

Protein Antibody Research 74

Scienmag

DECEMBER 27, 2021

In the 2002 science fiction blockbuster film Minority Report, Tom Cruise’s character John Anderton uses his hands, sheathed in special gloves, to interface with his wall-sized transparent computer screen. The computer recognizes his gestures to enlarge, zoom in, and swipe away.

82

82

Drug Channels

MARCH 14, 2023

I am pleased to announce our new 2023 Economic Report on U.S. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S. The 2023 Economic Report on U.S.

Pharmacy 87

Pharmacy Drugs Marketing 87

Pharmaceutical Technology

OCTOBER 1, 2022

Diarrhoea, nausea, upper respiratory tract infection and abdominal pain were reported to be the most common adverse events linked to Relyvrio. Additionally, treatment with Relyvrio substantially reduced physical function loss in ALS patients.

FDA Approval 244

FDA Approval Pharmacy Doctors Doctor 244

STAT News

JANUARY 19, 2023

What are the attributes of a great medical school? Read the rest…

Research 105

Research 105

STAT News

DECEMBER 22, 2022

As life-changing as methadone is, the catch is that taking the tightly regulated medication requires reporting to a special clinic nearly every day to get one’s dose. She finished a series of degrees, and is now a Ph.D. student in justice studies at Arizona State University. When the Covid-19 pandemic arrived, that changed.

Regulation 111

Regulation 111

Drug Channels

FEBRUARY 21, 2023

On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. This report—our fourteenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S. This report—our fourteenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S.

Pharmacy 76

Pharmacy Drugs Licensing Licensing 76

FDA Law Blog

JUNE 26, 2023

Houck — The Drug Enforcement Administration (“DEA”) has designated precursor chemicals, including 4-piperidone just last month, used in the illicit manufacture of controlled substances as List I and II chemicals over the years as “laboratory supplies,” but has never revised or updated its Special Surveillance List. 21 U.S.C. § 21 U.S.C. §

Manufacturing 53

Manufacturing Production Containment Drugs 53

Worldwide Clinical Trials

APRIL 8, 2024

Mitigation of Placebo Effects and Reporting Inaccuracies : In-house teams are adept at implementing strategies to minimize the risks associated with heightened placebo and nocebo response, inconsistent and inaccurate data reporting, as well as patient compliance issues, thereby preserving the trial’s scientific validity.

Clinical Research 165

Clinical Research Trials Clinical Trials Clinical Trials 165

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. The exhibit below—one of 241 in our new report—provides a first look at the 15 largest organizations, ranked by total U.S. We’re offering special discounted pricing if you order before April 3, 2023. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 88

Pharmacy Marketing Drugs 88

Pharma in Brief

APRIL 27, 2023

On April 26, 2023, the Office of the United States Trade Representative ( USTR ) released its 2023 Special 301 Report on intellectual property. The report keeps Canada on a Watch List of 29 U.S. The report is the USTR’s annual review of the global state of IP protection and enforcement.

Medicine 52

Medicine Life Science 52